Tenofovir
(asked on 2nd November 2016) - View Source
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty’s Government what discussions they have had with the pharmaceutical company Gilead Sciences about the extension of its patent for the drug tenofovir.
This question was answered on 14th November 2016
We are not aware of any such discussions. We are aware of three supplementary protection certificates (SPCs) granted in the UK to Gilead Sciences for products involving tenofovir disoproxil fumarate, of which one has been surrendered and two are the subject of revocation proceedings.